Eos publishes their proof of concept work in Molecular Therapy

Virally delivered Channelrhodopsin-2 Safely and Effectively Restores Visual Function in Multiple Mouse Models of Blindness

Virally delivered Channelrhodopsin-2 Safely and Effectively Restores Visual Function in Multiple Mouse Models of Blindness

M Mehdi Doroudchi, Kenneth P Greenberg, Jianwen Liu, Kimberly A Silka, Edward S Boyden, Jennifer A Lockridge, A Cyrus Arman, Ramesh Janani, Shannon E Boye, Sanford L Boye, Gabriel M Gordon, Benjamin C Matteo, Alapakkam P Sampath, William W Hauswirth and Alan Horsager

Eos Neuroscience, Inc., Los Angeles, California, USA
Division of Neurobiology, University of California Berkeley, Berkeley, California, USA
Department of Ophthalmology, University of Florida (UF), Gainesville, Florida, USA
Institute for Genetic Medicine, University of Southern California (USC), Los Angeles, California, USA
MIT Media Lab, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA
Zilkha Neurogenetic Institute, USC, Los Angeles, California, USA

Correspondence: Alan Horsager, Institute for Genetic Medicine, University of Southern California (USC), 2250 Alcazar Street, CSC 256, Los Angeles, California, 90089, 323–442-1978, USA. E-mail: horsager@usc.edu.

The full manuscript can be found here.